论文 · 综述
猪肾异种移植:从灵长类模型到临床现实
Porcine kidney xenotransplantation: From primate models to clinical reality
作者:Zihang Guo, Ling Zhang, Shoulong Deng, Chuan Qin
Animal Model Exp Med · 2026年5月8日 · Guo 等 4 位作者
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要)…
已等待 0 秒大约需要 10–20 秒
可以先看别的,做好了会自动出现在这里。
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。
摘要Abstract
The escalating global incidence of end-stage renal disease has exacerbated the critical shortage of kidneys from human donors. Porcine kidney xenotransplantation has emerged as the most promising alternative solution to providing an unlimited organ supply. In this review, we examine the historical evolution, current breakthroughs and future directions of kidney xenotransplantation. We probe the milestones from early attempts and non-human primate (NHP) experiments to recent clinical trials involving both brain-dead and living human recipients. The core of this review provides an in-depth discussion of the significant barriers in kidney xenotransplantation, including immune rejection, physiological incompatibilities and the risk of cross-species infection. Next, we systematically outline the multifaceted strategies developed to overcome these barriers. The rapid development of gene editing technology has enabled the establishment of multigene-edited pigs. These donors feature knockout of key carbohydrate antigen genes and expression of various human proteins, including complement regulators, anticoagulants, and immunomodulators. These genetic modifications have extended xenograft survival in NHP models to over 750 days. This is synergized with novel immunosuppressive regimens, tolerance-induction protocols, cellular therapies, and emerging adjuncts like bioengineering materials and organoid-on-a-chip technologies. Finally, we discuss future directions, raising concerns about potential complications arising from the biomechanical incompatibility between pigs and human in xenotransplantation, highlighting the need to deploy advanced multi-omics to identify unknown xenoantigens, optimize bioengineering materials for local immunomodulation, and validate extracellular vesicles as non-invasive biomarkers. While challenges for long-term xenograft survival remain, kidney xenotransplantation is rapidly advancing from preclinical research to clinical reality, holding huge potential to resolve the organ shortage crisis.
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究,以及之后引用它的研究,并说明每篇为什么相关。